Milagro Perryman is a Hempstead, New York based nurse practitioner. Active license number of Milagro Perryman is 301465 in New York. Her current practice location is 210 Fulton Ave, Hempstead. Patients can reach her at 718-765-6001 or can fax her at 516-461-2893. Milagro Perryman is N.P. and her NPI number (Unique professional ID assigned by NPPES) is 1932332251. Milagro Perryman has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Milagro Perryman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1932332251
NPI Enumeration Date:
03 Sep, 2009
NPI Last Update On:
15 Dec, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Milagro Perryman are as mentioned below.
License Number
Specialization
State
Status
301465
New York
Primary
421010
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Milagro Perryman Po Box 746087, Atlanta, Georgia
Zip:
30374-6087
Phone Number:
312-733-9730
Patients can reach Milagro Perryman at 210 Fulton Ave, Hempstead, New York or can call to book an appointment on 718-765-6001.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.